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Background: Breast metastasis from extramammary malignancy is uncommon and often presents diagnostic
challenges. Herein, we report a case of a patient with metachronous isolated breast metastasis from pulmonary
adenocarcinoma with micropapillary component.
Case presentation: A 47-year-old woman presented with left breast nodule detected on a screening breast
ultrasonography. She had surgery for pulmonary adenocarcinoma 3 years ago, and was disease-free state in the
follow up studies. The patient was diagnosed with invasive micropapillary carcinoma of the breast by core needle
biopsy. She underwent left breast lumpectomy and sentinel lymph node biopsy, and the histologic findings revealed
micropapillary carcinoma. Based on the immunohistochemical study, the final diagnosis was solitary breast metastasis
from pulmonary adenocarcinoma with micropapillary component.
Conclusions: The diagnosis of metastasis to the breast from extramammary malignancies is difficult but important for
proper management and prediction of prognosis. A careful clinical history with a thorough clinical examination is
needed to make the correct diagnosis.
Keywords: Breast metastasis, Pulmonary adenocarcinoma, Micropapillary component, Lung cancerBackground
Metastases to the breast from extramammary malignancy
are relatively rare though breast cancer is the most com-
mon malignancy in women [1]. Most malignancies seen in
the breast are primary carcinomas [2] and the incidence of
metastatic disease to the breast is 0.2-6.6% of all malignant
breast tumors [3-8]. The primary malignancies most com-
monly metastasizing to the breast are leukemia, lymph-
oma, malignant melanoma and carcinomas from the lung,
genitourinary or gastrointestinal tract [9-11]. These meta-
static tumors can morphologically simulate breast cancer
and lead to misclassification [11], which causes clinical
problems because the treatment and prognosis of each
tumor differs significantly.
Although lung cancer is one of most common cancer
worldwide, there have been only a few published cases
of pulmonary carcinoma metastasizing to the breast,* Correspondence: sunghwa@cu.ac.kr
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unless otherwise stated.particularly with micropapillary component [12-14]. In-
vasive micropapillary carcinomas have been described in
several organs including urinary bladder, lung, major sa-
livary glands, ovary and breast [15]. Adenocarcinoma with
micropapillary component is a morphologic variant of
carcinoma and usually recognized as a poor prognostic
predictors [15]. We report a case of metachronous isolated
breast metastasis from pulmonary adenocarcinoma with
micropapillary component which was initially favored to
be primary breast cancer. The institutional review board at
Daegu Catholic University Hospital granted an exemption
from requiring ethics approval for this study.
Case presentation
A 47-year-old Korean woman presented to the Daegu
Catholic University Hospital in Korea with a nodule re-
vealed by screening breast ultrasonography in her left
breast. On the physical examination, there was no palp-
able mass or nipple discharge in both breasts. There was
no clinical evidence of regional lymphadenopathy. She
had no family history of breast or ovarian cancers. Shetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 Core needle biopsy of left breast tumor. Microscopic
findings of the specimen showed proliferation of micropapillae of
anaplastic cells in the clear spaces which were consistent with
invasive micropapillary carcinoma of the breast (H&E stain, ×400).
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because of a pulmonary adenocarcinoma 3 years ago.
The pathologic diagnosis was 3.5 cm-sized adenocarcin-
oma with micropapillary component, and the pathologic
stage of lung cancer was T2aN0M0, stage IB.
Mammography revealed only a focal asymmetry in left
upper breast and benign calcifications in both breasts
(Figure 1A). Ultrasonography revealed two irregular
shaped and microlobulated hypoechoic small masses in
left upper breast, which was categorized according to
Breast Imaging Report and Data System (BI-RADS) as
BI-RADS 4C (Figure 1B). The patient underwent
ultrasound-guided core needle biopsy. Initial histologic
findings revealed proliferation of micropapillae of ana-
plastic cells in the clear spaces which were consistent
with invasive micropapillary carcinoma of the breast
(Figure 2). Magnetic resonance imaging of the breast
showed no significantly enhancing lesion in both breast.
Chest computed tomography (CT) revealed probable
benign sub-pleural nodule in right lower lobe but no
tumor recurrence or nodal metastasis of lung cancer.
On a position emission tomography-CT image there
was no evidence of tumor recurrence of lung cancer or
distant metastasis.
Clinically, primary breast cancer was suspected, and the
patient underwent lumpectomy and sentinel lymph node
biopsy using radio-isotope and indigocarmine dye. Gross
examination of the specimen revealed an irregular shaped
whitish fibronodular lesion, measuring 1.3 × 1 cm in size
(Figure 3A). The specimen was fixed in 10% formalin, and
paraffin sections were prepared. Hematoxylin and eosin
(H&E)-stained paraffin sections of the lumpectomy spe-
cimen revealed extensive micropapillary components
(Figure 3B). Microscopic examination of the sections
from the specimen showed small clusters of cells within
clear stromal spaces resembling dilated vascular channels
(Figure 3C) with a desmoplastic reaction. There were no
ductal components and carcinoma in situ lesions. There
were lymphovascular invasion and some microscopic mul-
tiple tumor foci, but resection margins were free fromFigure 1 Radiologic findings of the left breast. (A) Mammography show
both breasts (B) Ultrasonography showing irregular shaped and microlobutumor. The tumor cells showed triple negative immu-
noreactivity for estrogen receptor (ER), progesterone
receptor (PR) and HER2/neu. The immunohistoche-
mical staining for gross cystic disease fluid protein-15
(GCDFP-15) (Figure 4A) and anaplastic lymphoma kin-
ase (ALK) was negative, but, that for thyroid transcrip-
tion factor-1 (TTF-1), cytokeratin-7 (CK-7) and Napsin
A was positive (Figure 4B-4D). There was no axillary
lymph node metastasis. Based on the histology and the
immunohistochemical staining patterns, this breast tumoring a focal asymmetry in left upper breast and benign calcifications in
lated hypoechoic small mass in left upper breast.
Figure 3 Histologic findings of the left breast tumor after lumpectomy. (A) Gross findings of the specimen showed an irregular shaped
whitish fibronodular lesion. (B) Hematoxylin and eosin (H&E)-stained paraffin sections of the lumpectomy specimen revealed extensive
micropapillary components (H&E stain, ×40). (C) Microscopic findings of the specimen showed small clusters of cells within clear stromal
spaces resembling dilated vascular channels with a desmoplastic reaction (H&E stain, ×400).
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pulmonary malignancy.
We reviewed the histopathologic findings of the lung
cancer removed 3 years ago and compared them with
the findings of the breast tumor. H&E-stained paraffin
sections of the lung cancer revealed diffuse infiltration
of malignant epithelioid cells showing solid and micro-
papillary patterns, which resemble the findings of the
breast tumor. Also, the lung cancer had the same immu-
noprofiles as the breast tumor.
We analyzed the mutation of EGFR gene in the breast
tumor and the original pulmonary adenocarcinoma speci-
men. Once informed consent had been obtained, genomic
DNA was extracted from paraffin-embedded tumor spe-
cimens using QIAamp DNA FFPE Tissue kit (Qiagen,
Hilden, Germany) following the manufacturer’s instruc-
tions. Polymerase chain reaction and mutational analyses of
the genes were performed. Exon 18, 19, 20 and 21 of the
EGFR gene were analyzed by direct sequencing. DNA se-
quencing was performed on the pretreated PCR product
using an automated direct sequence analyzer (ABI PRISM
3100 Genetic Analyzer; Applied Biosystems, Foster City,CA, USA). The mutationl analysis revealed same het-
erozygote mutation in both of the specimens. There was
a 9-bp deletion in exon 19, namely, c.2239_2247del9,
which resulted in a deletion of three amino acids,
namely p.L747_E749del (Figure 5).
From the above results, the patient was diagnosed soli-
tary breast metastasis from pulmonary adenocarcinoma
with micropapillary component. Since the mutation test
for EGFR was positive, the patient has been taking
Gefitinib, being disease-free at 23 month after the
diagnosis of the breast metastasis.
Conclusions
The breast is an unusual site for metastasis from extra-
mammary tumors and metastatic cancer is an unex-
pected diagnosis in a woman presenting with a breast
mass [16,17]. The distinction between breast metastasis
from extramammary malignancy and primary breast
cancer is important for patient management [11]. Some
authors have described clinical and histological charac-
teristics of breast metastasis from extramammary malig-
nancies [5,8,11,18]. The most common symptoms are
Figure 4 Immunohistochemical staining of the left breast tumor after lumpectomy. (A) GCDFP-15 stain was negative in malignant cells
(×400). (B) TTF-1 stain reveals nuclear positivity (×400). (C) CK-7 stain was positive in malignant cells (×400). (D) Napsin A stain was positive in
malignant cells (×400).
Jeong et al. BMC Cancer 2014, 14:736 Page 4 of 8
http://www.biomedcentral.com/1471-2407/14/736solitary discrete lesions in the breast [5,11], while in one
study, most patients presented with a history of loco-
regional and wide spread metastases of extramammary
neoplasms [18]. The most common mammographic ap-
pearance is of a round mass with well-defined or slightly
irregular margins [11,18]. In our patient, mammography
revealed only a focal asymmetry in left upper and ultra-
sonography revealed two irregular shaped and microlo-
bulated hypoechoic small masses in left upper breast
categorized according to BI-RADS 4C. Histological
features of metastases to the breast include atypical
histologic features for a primary breast carcinoma, a
well-circumscribed tumor with multiple satellite foci,
the absence of an intraductal component, and the pres-
ence of many lymphatic emboli [4]. However, pathologic
diagnosis of breast metastases is difficult, because many
extramammary malignancies lack specific histological fea-
tures and sometimes the features are similar to thoseof primary breast cancer, particularly with extensive
micropapillary patterns [12,13].
Clinical history, radiologic findings and histologic fea-
tures are helpful in the evaluation of metastatic lesions in
the breast. In a review of the ultrasonographic appear-
ances of breast metastases from extramammary malignan-
cies, there are several typical features of breast metastases
[19]. Typical ultrasound features of hematogenous metas-
tases include single or multiple, round to oval shaped,
well-circumscribed hypoechoic masses without spicula-
tions, calcifications, or architectural distortion [19]. How-
ever, lesions show variable radiologic features in some
cases and a possibility of a metastasis should be suspected
for a breast tumor in a patient with a history of cancer,
even if clinically or radiologically benign [20]. Most of pri-
mary breast carcinomas originate in the ducts or lobules
of the breast and the presence of an in situ (intraductal)
component is the only absolute proof of the primary
Figure 5 Sequencing results of the heterozygote mutations c.2239_2247del9 (p.L747_E749del) of EGFR gene in breast tumor specimen
(A) and lung adencarcinoma specimen (B).
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circumscribed tumor is identified in the breast showing
lack of in situ components, the possibility of metastatic
cancer should be considered and excluded [21], especially
in high grade tumors without an in situ component. Also,
ER and PR are highly specific markers for breast cancer
[11] and ER/PR negative breast tumor without an in situ
component is the most common clue for suspicion of
metastatic tumor in the breast.
Immunohistochemical studies are necessary for patho-
logic diagnosis if no primary tumor was known and the
clues are subtle to show specific histological features
[4,11]. An immunohistochemical analysis using a panel of
antibodies may be useful to discriminate a primary mam-
mary tumor from an extramammary malignancy because
specificity or sensitivity of specific markers is not always
100% [11]. The combination CK7 and CK20 is useful in
categorizing carcinomas [11,22]. The most of breast
carcinomas are CK7+ and CK20-, and a CK20+ or CK7-
pattern would make breast origin less likely [22]. GCDFP-
15 is also highly specific marker for breast cancer [11].
TTF-1 is a very useful marker in distinguishing pulmonary
adenocarcinomas from other primary carcinomas. TTF-1is expressed in about 75% of pulmonary adenocarcin-
omas [11], and no breast carcinomas have been re-
ported to be positive for TTF-1 except rare small cell
carcinomas of the breast [23,24]. Napsin A is a new
marker for pulmonary adenocarcinoma and is known to
be more sensitive and specific than TTF-1 in the differ-
ential diagnosis of primary pulmonary carcinoma [25].
In our case, the tumor cells showed negative immunore-
activity for ER, PR, HER2/neu and GCDFP-15, and
positive for TTF-1, CK-7 and Napsin A.
In a systematic review of the literature, 43 independent
case reports were identified for primary lung cancer me-
tastasis to the breast [26]. Of these 43 case reports, only
3 case reports revealed metastasis to the breast from
pulmonary adenocarcinoma with a micropapillary com-
ponent (Table 1). These 3 previous reports [12-14] have
described synchronous lung cancer with breast metasta-
sis and demonstrated similar histologic features of breast
biopsy including adenocarcinoma with micropapillary
component, lymphovascular invasion (lymphatic tumor
emboli) and desmoplastic reaction such as dense fibro-
hyalinized stroma. Maounis et al. [13] and Sanguinetti
et al. [14] and also described multiple psammoma bodies
Table 1 Clinical features of case reports of breast metastasis from pulmonary adenocarcinoma with micropapillary components











Ko K, et al., 2012 [12] 47/F Chest pain
with dyspnea
Palpable mass on P/Ex. 1 cm in diameter No IV Chemotherapy Cisplatin/Irinotecan
followed by erotinib
Alive 8 mo




Palpable mass on P/Ex Not available No IV Chemotherapy Cisplatin/docetaxel/
bevacizumab
Dead 6 mo









This report 47/F Breast nodule on
screening exam
Ultrasonography 1.3 cm ×1 cm Yes IB Lumpectomy +
Chemotherapy
Gefitinib Alive 23 mo
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lary component, desmoplastic reaction and lymphovascu-
lar invasion were identified, but psammoma body was not
observed. To the best of our knowledge this is the first re-
port of metachronous breast metastasis from pulmonary
adenocarcinoma with micropapillary component.
It has been documented that breast metastasis from
extramammary malignancy has a poor prognosis because
most patients have been reported as widely disseminated
disease and die within a year of diagnosis [10,11]. Specific-
ally, synchronously-presenting lung cancer metastasizing
to the breast, namely stage IV lung cancer has carried a
very poor prognosis [26]. For patients presenting syn-
chronous lung cancer with breast metastasis, removal of
the breast lesion offers no patient benefit [26]. However,
removal of the breast lesion could be a useful treatment
option for patients with metachronously-presenting lung
cancer metastasizing to the breast only, although it has
not been established yet whether surgical treatment will
affect the prognosis or not. In our case, the patient had
only metastasis to the breast and was treated with surgery
and anti-EGFR (Gefitinib) treatment. She has been sur-
vived with disease free for 23 months following the diag-
nosis of the breast metastasis.
Micropapillary component is generally thought to have
prognostic significance and is associated with a manifest-
ation of aggressive behavior such as lymph node metasta-
ses and distant metastases [27,28]. In 3 previous reports
[12-14] of synchronously-presenting breast metastasis
from pulmonary adenocarcinoma with a micropapillary
component, 2 patients died 6 months and 8 months fol-
lowing diagnosis, respectively [13,14], and a patient
were alive 8 months after the initial diagnosis of lung
cancer [12], although all patients have received systemic
chemotherapy. Our patient is currently alive without
additional metastasis 23 months after the diagnosis of the
breast metastasis, but long-term follow-up is needed.
Here, we report a rare case of metachronous isolated
metastasis to the breast from a pulmonary adenocarcin-
oma with micropapillary component. The distinction be-
tween breast metastasis from pulnomary adenocarcinoma
with micropapillary component and primary breast micro-
papillary carcinoma may cause diagnostic challenges. An
immunohistochemical analysis is useful for accurate diag-
nosis. Furthermore, although it is rare, the possibility of
metastatic disease to the breast should be considered
before making the diagnosis of primary breast cancer,
particularly with micropapillary component.
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